ProfileGDS4718 / 217612_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 66% 59% 56% 61% 56% 69% 65% 65% 62% 60% 65% 47% 54% 70% 70% 62% 63% 62% 69% 49% 64% 62% 65% 60% 61% 67% 61% 61% 61% 68% 63% 75% 56% 60% 58% 57% 62% 62% 60% 57% 61% 61% 52% 73% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.5911566
GSM549102patient 115, normal, homogenized [OPG study]6.0663659
GSM549104patient 119, normal, homogenized [OPG study]5.8411856
GSM549108patient 138, normal, homogenized [OPG study]6.2153661
GSM549119patient 077, normal, homogenized [OPG study]5.8728156
GSM549133patient 032, cancer, homogenized [OPG study]6.8681369
GSM549139patient 042, cancer, homogenized [OPG study]6.5014865
GSM549099patient 107, normal, homogenized [OPG study]6.4236865
GSM549109patient 139, normal, homogenized [OPG study]6.2463262
GSM549110patient 046, normal, homogenized [OPG study]6.1498460
GSM549114patient 063, normal, homogenized [OPG study]6.4759865
GSM549122patient 082, normal, homogenized [OPG study]5.3804147
GSM549134patient 033, cancer, homogenized [OPG study]5.7473454
GSM549136patient 036, cancer, homogenized [OPG study]6.9228870
GSM549140patient 044, cancer, homogenized [OPG study]6.8978870
GSM549111patient 047, normal, homogenized [OPG study]6.2543262
GSM549113patient 057, normal, homogenized [OPG study]6.3095663
GSM549132patient 031, cancer, homogenized [OPG study]6.2901662
GSM549137patient 038, cancer, homogenized [OPG study]6.773769
GSM549142patient 047, cancer, homogenized [OPG study]5.5712649
GSM549100patient 110, normal, homogenized [OPG study]6.3915364
GSM549107patient 135, normal, homogenized [OPG study]6.2507562
GSM549115patient 068, normal, homogenized [OPG study]6.4712965
GSM549116patient 072, normal, homogenized [OPG study]6.1440560
GSM549120patient 078, normal, homogenized [OPG study]6.2233361
GSM549131patient 030, cancer, homogenized [OPG study]6.6122267
GSM549118patient 074, normal, homogenized [OPG study]6.1907261
GSM549129patient 027, cancer, homogenized [OPG study]6.2279661
GSM549123patient 088, normal, homogenized [OPG study]6.2150661
GSM549124patient 006, cancer, homogenized [OPG study]6.6940468
GSM549126patient 015, cancer, homogenized [OPG study]6.3544663
GSM549128patient 025, cancer, homogenized [OPG study]7.3839875
GSM549103patient 117, normal, homogenized [OPG study]5.8751756
GSM549117patient 073, normal, homogenized [OPG study]6.0878160
GSM549138patient 041, cancer, homogenized [OPG study]5.9794958
GSM549141patient 045, cancer, homogenized [OPG study]5.9012857
GSM549130patient 028, cancer, homogenized [OPG study]6.2299562
GSM549101patient 111, normal, homogenized [OPG study]6.2701862
GSM549105patient 128, normal, homogenized [OPG study]6.1446560
GSM549106patient 134, normal, homogenized [OPG study]5.8700157
GSM549112patient 048, normal, homogenized [OPG study]6.1842161
GSM549125patient 011, cancer, homogenized [OPG study]6.1683461
GSM549127patient 024, cancer, homogenized [OPG study]5.6503952
GSM549135patient 035, cancer, homogenized [OPG study]7.1831173